logo

For the Inventor, By the Inventor

Branchburg, NJ, United States of America

William Edward Konnecke

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Signal Pharmaceuticals, Inc.. Active years: 2017-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Edward Konnecke. Retrieved from https://idiyas.com/inventor/william-edward-konnecke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 100.0


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal3 out of 169 
 
Signal Pharmaceuticals, Inc.
 patents

Years Active: 2017-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents
1. 9974786 - [object Object] (2018-05-22),
2. 9795603 - Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use (2017-10-24),
3. 9604939 - Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-YL)pyridin-3-YL)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use (2017-03-28),

Title: William Edward Konnecke: Innovator in Pharmaceutical Compositions

Introduction

William Edward Konnecke is a notable inventor based in Branchburg, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on innovative compositions that have the potential to treat various diseases and disorders.

Latest Patents

Konnecke's latest patents include compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one, along with solid forms, isotopologs, and metabolites thereof. These compositions are designed for the treatment of specific diseases, disorders, or conditions. Another patent details pharmaceutical compositions of the same compound, emphasizing solid forms and methods of use.

Career Highlights

William Edward Konnecke is currently associated with Signal Pharmaceuticals, Inc., where he continues to advance his research and development efforts in the pharmaceutical sector. His innovative work has positioned him as a key player in the industry.

Collaborations

Konnecke has collaborated with notable colleagues, including Marie Georges Beauchamps and Antonio Christian Ferretti. These partnerships have contributed to the success of his projects and the advancement of pharmaceutical innovations.

Conclusion

William Edward Konnecke's contributions to pharmaceutical compositions demonstrate his commitment to innovation in the field. His patents reflect a dedication to improving treatment options for various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…